《亞洲市況》日經半日跌236點 軟銀集團逆升3.3%
美國勞工部上週五(4日)公佈今年1月就業報告全面強勁,非農業就業人數大幅增加46.7萬人,不僅遠超市場預期的12.5萬人,且比去年12月時的19.9萬人增加逾一倍;市場預料聯儲局將加快加息步伐。日經指數扭轉上週五升勢,今早(7日)低開112點後,初段曾跌354點,低見27,085,隨後跌幅收窄,半日收跌236點或0.86%,報27,203。美元兌日圓報115.28。
主要金融股逆市造好,三井住友金融、三菱日聯、瑞穗及大和升1.1%至2.1%、Resona控股升3.1%、野村微升0.4%。
權重股分化,石油股Inpex、ENEOS及出光興產各升逾1%;另軟銀集團升3.3%,其持股阿裏巴巴(09988.HK)(BABA.US)發出英文公告,指已向美國證交會(SEC)提交F-6文件,計劃額外註冊10億份美國存託股票(ADS),每份代表8股普通股。有市場分析指,阿裏或有意配股,故提前作準備。迅銷則跌1.7%。
半導體板塊跑輸,Advantest、信越化學及Sumco挫3.6%至8.7%。精密設備股同受壓,Minebea Mitsumi跌4.3%、Olympus及太陽誘電跌9.6%至10.8%。Olympus截至去年底止首三財季經營溢利按年升68.2%至1,089.1億日圓(約9.48億美元),另太陽誘電首三財季經營溢利升72.5%至523億日圓(約4.55億美元)。
鹽野義製藥(Shionogi)升2%,日本《每日新聞》報道,日本正在考慮批準其最早在今年春季開始銷售抗新冠病毒口服藥,較早時該藥獲準跳過進行最後階段臨牀測試。鹽野義於1月17日表示,開始在日本爲新冠疫苗進行第3期測試,會將測試結果與已獲批準的疫苗進行比較。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.